Form 4: Jeffrey Crisan, LifeStance Health Group Director, Reports Sale of Shares

Sentiment:

SEC Form 4


Director Jeffrey Crisan reports the sale of 1,624,638 shares of LifeStance Health Group, Inc. at $5.89 per share on May 24, 2024.

Summary

  • On May 24, 2024, Jeffrey Crisan, a director at LifeStance Health Group, Inc., sold 1,624,638 shares of common stock at a price of $5.89 per share.
  • Following the transaction, Mr. Crisan indirectly beneficially owns 17,916,554 shares through his affiliation with Silversmith Partners I GP, LLC and related entities.
  • Mr. Crisan disclaims beneficial ownership of these securities except to the extent of his pecuniary interest.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting a transaction. It doesn't inherently convey positive or negative sentiment.

Management Comments

  • Mr. Crisan disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Stakeholder Impact

  • The sale of shares by a director could potentially influence investor sentiment.

Key Dates

DateDescription
05/24/2024Date of the transaction: sale of common stock.
05/29/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.